EV/EBITDA
-1.87
+0.14+6.97%
6 min ago
Summary
- As of February 7, 2025, ADAP EV/EBITDA is -1.87, with a rise of +0.14 (+6.97%) during the most recent trading day.
- Over the past year, ADAP EV/EBITDA has dropped by -0.56 (-42.75%).
- ADAP EV/EBITDA is now -523.33% below its all-time high of -0.30.
Performance
ADAP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ADAP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +7.0% | -6.9% | -5.1% |
| 1 m1 month | +13.8% | -13.9% | -10.4% |
| 3 m3 months | - | - | -25.3% |
| 6 m6 months | -33.6% | +19.7% | -41.3% |
| ytdytd | -10.7% | +10.7% | +7.4% |
| 1 y1 year | -42.8% | -36.3% | -53.8% |
| 5 y5 years | +51.0% | -78.8% | -85.7% |
ADAP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -7.5% | -2.30 | +18.7% | |
| 3 m | 3-month | -1.69 | -10.7% | -2.57 | +27.2% |
| 6 m | 6-month | -1.16 | -61.2% | -2.63 | +28.9% |
| 1 y | 1-year | -0.53 | -252.8% | -3.11 | +39.9% |
| 3 y | 3-year | -0.30 | -523.3% | -3.11 | +39.9% |
| 5 y | 5-year | -0.30 | -523.3% | -13.19 | +85.8% |
| alltime | all time | -0.30 | -523.3% | -257.80 | +99.3% |
Adaptimmune Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.87(+10.7%) |
| 2024 | -1.69(+259.6%) |
| 2023 | -0.47(-52.0%) |
| 2022 | -0.98(-66.9%) |
| 2021 | -2.96(-53.5%) |
| Date | Value |
|---|---|
| 2020 | -6.37(+727.3%) |
| 2019 | -0.77(-89.2%) |
| 2018 | -7.12(-1.1%) |
| 2017 | -7.20(+297.8%) |
| 2016 | -1.81(-96.8%) |
| 2015 | -56.20 |
FAQ
- What is Adaptimmune Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Adaptimmune Therapeutics?
- What is ADAP EV/EBITDA year-to-date change?
- What is Adaptimmune Therapeutics EV/EBITDA year-on-year change?
What is Adaptimmune Therapeutics EV/EBITDA?
The current EV/EBITDA of ADAP is -1.87
What is the all time high EV/EBITDA for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high EV/EBITDA is -0.30
What is ADAP EV/EBITDA year-to-date change?
Adaptimmune Therapeutics EV/EBITDA has changed by -0.18 (-10.65%) since the beginning of the year
What is Adaptimmune Therapeutics EV/EBITDA year-on-year change?
Over the past year, ADAP EV/EBITDA has changed by -0.56 (-42.75%)